Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2022 | FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells | Chuang, HH; Huang, MS; Zhen, YY; Chuang, CH; Lee, YR; Hsiao, M ; Yang, CJ | BIOMEDICINES 10(8), 1937 | | | |
2022 | FAK in Cancer: From Mechanisms to Therapeutic Strategies | Chuang, HH; Zhen, YY; Tsai, YC; Chuang, CH; Hsiao, M ; Huang, MS; Yang, CJ | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23(3), 1726 | | | |
2022 | FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis | Li, LJ; Chang, PM; Li, CH; Lai, TC; Chang, YC; Su, CY; Chen, CL; Chang, WM; Hsiao, M ; Fung, SW | CELL DEATH DISCOVERY 8, 101 | | | |
2017 | Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression | Chang, YC; Chan, YC; Chang, MW; Lin, YF; Yang, CJ; Su, CY; Huang, MS; Wu, AT; Hsiao, M | Cancer Letters 403, 28-36 | | | |
2022 | Fibroblasts Drive Metabolic Reprogramming in Pacemaker Cardiomyocytes | Pei-Chun Chou; Chih-Min Liu; Ching-Hui Weng; Kai-Chien Yang ; Mei-Ling Cheng; Yuh-Charn Lin; Ruey-Bing Yang ; Bai-Chuang Shyu ; Song-Kun Shyue ; Jin-Dian Liu; Shih-Pin Chen; Michael Hsiao ; Yu-Feng Hu | Circulation research 131(1), 6-20 | | | |
2019 | Follistatin-like protein 1 inhibits lung cancer metastasis by preventing proteolytic activation of osteopontin | Chiou, J; Chang, YC; Tsai, HF; Lin, YF; Huang, MS; Yang, CJ; Hsiao, M | Cancer Research 79(24), 6113-6125 | | | |
2019 | FOXD1 and Gal-3 form a positive regulatory loop to regulate lung cancer aggressiveness | Li, CH; Chang, YC; Hsiao, M ; Liang, SM | Cancers 11(12), 1897 | | | |
2021 | Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives | Li, CH; Chang, YC; Chan, MH; Yang, YF; Liang, SM ; Hsiao, M | BIONMEDICINES 9(9), 1159 | | | |
2017 | Ghrelin and cancer progression | Lin, TC; Hsiao, M | Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868(1), 51-57 | | | |
2019 | Ghrelin upregulates oncogenic Aurora A to promote renal cell carcinoma invasion | Lin, TC; Yeh, YM; Fan, WL; Chang, YC; Lin, WM; Yang, TY; Hsiao, M | Cancers 11(3), 303 | | | |
2017 | Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma | Chi, LH; Chang, YC; Chang, WM; Chan, YC; Tai, CC; Leung, KW; Chen, CL; Wu, ATH; Lai, TC; Li, YCJ; Hsiao, M | Scientific Reports 7, 9031 | | | |
2023 | Glucose Transporter 4: Insulin Response Mastermind, Glycolysis Catalyst and Treatment Direction for Cancer Progression | Chang, Yu-Chan; Chan, Ming-Hsien; Yang, Yi-Fang; Li, Chien-Hsiu; Hsiao, Michael | CANCER LETTERS 563, 216179 | | | |
2007 | Glycine N-methyltransferase−/− mice develop chronic hepatitis and glycogen storage disease in the liver | Liu, S. P.; Li, Y. S.; Chen, Y. J.; Chiang, E. P.; Li, A. F. Y.; Lee, Y. H. ; Tsai, T. F.; Hsiao, M. ; Chen, Y. M. | Hepatology 46(5), 1413-1425 | | | |
2016 | Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity. | S.-C. Yeh; P.-Y. Wang; Y.-W. Lou; K.-H. Khoo ; M. Hsiao ; T.-L. Hsu ; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 113(20), 5592-5597 | | | |
2023 | Gold Nanoparticles as a Biosensor for Cancer Biomarker Determination | Li, Chien-Hsiu; Chan, Ming-Hsien; Chang, Yu-Chan; Hsiao, Michael | MOLECULES 28(1), 364 | | | |
2019 | Graphitic carbon nitride-based nanocomposites and their biological applications: a review. | Chan, MH; Liu, RS; Hsiao, M | Nanoscale 11(32), 14993-15003 | | | |
2019 | High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma | CH Lin; HY Li; YP Liu; PF Kuo; WC Wang; FC Lin; WL Chang; BS Sheu; YC Wang; WC Hung; HC Cheng; YC Yao; MJ Calkins.; M Hsiao ; PJ Lu | Therapeutic Advances in Medical Oncology 11, 1758835919875324 | | | |
2021 | Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122 | Yuan, LT; Lee, WJ; Yang, YC; Chen, BR; Yang, CY; Chen, MW; Chen, JQ; Hsiao, M ; Chien, MH; Hua, KT | CANCERS 13(10), 2376 | | | |
2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | | | |
2021 | Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates | Yeh, YC; Lawal, B; Hsiao, M ; Huang, TH; Huang, CF | BIOMEDICINES 9(11), 1582 | | | |